Cytosorbents Corp Files Q1 2025 10-Q

Ticker: CTSO · Form: 10-Q · Filed: May 14, 2025 · CIK: 1175151

Cytosorbents CORP 10-Q Filing Summary
FieldDetail
CompanyCytosorbents CORP (CTSO)
Form Type10-Q
Filed DateMay 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financial-report, medical-devices

TL;DR

**Cytosorbents Corp Q1 2025 10-Q filed. Expect financial updates.**

AI Summary

Cytosorbents Corporation filed a 10-Q for the period ending March 31, 2025. The company, formerly known as MedaSorb Technologies CORP, is based in Princeton, NJ. Key financial details and operational updates are expected within this filing, which follows their previous name change from GILDER ENTERPRISES INC in 2006.

Why It Matters

This filing provides crucial financial and operational insights into Cytosorbents Corp's performance for the first quarter of 2025, impacting investor decisions and market perception.

Risk Assessment

Risk Level: medium — As a publicly traded company filing a quarterly report, there are inherent risks associated with financial performance and market fluctuations.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Cytosorbents Corp?

The filing indicates Cytosorbents Corp is in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry (SIC code 3841).

When was the company formerly known as MedaSorb Technologies CORP?

The name change from MedaSorb Technologies CORP to Cytosorbents Corp occurred on August 7, 2006.

What is the fiscal year end for Cytosorbents Corp?

The company's fiscal year ends on December 31st.

Where is Cytosorbents Corp located?

The company's business and mailing address is 305 College Road East, Princeton, NJ 08540.

What is the SEC file number for Cytosorbents Corp?

The SEC file number is 001-36792.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Cytosorbents Corp (CTSO).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing